Responses
Extended report
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016Lymphomas and TNF alpha inhibitorsShow More
Dear Editor,
There are issues that deserve more thought and discussion as they relate to the Geborak et al. paper [1] on the tumour and lymphoma incidence associated with TNF alpha inhibitor use. The title says a) these drugs do not raise the overall incidence of tumours and b) they may be associated with an increased risk of lymphoma. Given that lymphomas are also counted under tumours, I cannot see how "a" and...
Conflict of Interest:
None declared.